Sino Medical Sciences Technology In Asset Resilience Ratio
Sino Medical Sciences Technology In asset resilience ratio. Sino Medical Sciences Technology In (688108) has an Asset Resilience Ratio of 0.66% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Sino Medical Sciences Technology In fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sino Medical Sciences Technology In (None–None)
Asset resilience ratio of Sino Medical Sciences Technology In from None to None. This chart shows how Sino Medical Sciences Technology In's Asset Resilience Ratio has changed over time. Read Sino Medical Sciences Technology In total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Sino Medical Sciences Technology In's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Sino Medical Sciences Technology In (688108) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥8.54 Million | 0.66% |
| Total Liquid Assets | CN¥8.54 Million | 0.66% |
Asset Resilience Insights
- Limited Liquidity: Sino Medical Sciences Technology In maintains only 0.66% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sino Medical Sciences Technology In Industry Peers by Asset Resilience Ratio
Compare Sino Medical Sciences Technology In's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Sino Medical Sciences Technology In Asset Resilience Ratio by Year (None–None)
Sino Medical Sciences Technology In asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Sino Medical Sciences Technology In.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Sino Medical Sciences Technology In
Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional medical devices in China. Its products include coronary drug stents, coronary balloons catheter, intracranial rapid exchange balloons, and intracranial drug-eluting stents, as well as transapical mitral valve replacement system. Sino Medical Science… Read more